|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | C07D 217/26 | (2006.01) |
| A61K 31/47 | (2006.01) |
| (11) | Number of the document | 2872488 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13740185.7 |
| Date of filing the European patent application | 2013-07-15 | |
| (97) | Date of publication of the European application | 2015-05-20 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-22 |
| (46) | Date of publication of the claims translation | 2018-10-25 |
| (86) | Number | PCT/US2013/050539 |
| Date | 2013-07-15 |
| (87) | Number | WO 2014/014835 |
| Date | 2014-01-23 |
| (30) | Number | Date | Country code |
| 201261672191 P | 2012-07-16 | US | |
| 201361768297 P | 2013-02-22 | US | |
| 201361832566 P | 2013-06-07 | US |
| (72) |
WITSCHI, Claudia, US
PARK, Jung Min, US
THOMPSON, Michael, D., US
MARTINELLI, Michael, John, US
YEOWELL, David, A., US
AREND, Michael, P., US
|
| (73) |
Fibrogen, Inc.,
409 Illinois Street, San Francisco, CA 94158,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kristalinės prolilhidroksilazės inhibitoriaus formos |
| CRYSTALLINE FORMS OF A PROLYL HYDROXYLASE INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2023-06-20 | 11 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2024-03-25 |